NCT03233100 is a NA clinical trial of FMT in Constipation - Functional, sponsored by Jianfeng Gong.

Who is sponsoring NCT03233100?

NCT03233100 is sponsored by Jianfeng Gong.

What drugs are being tested in NCT03233100?

Interventions in NCT03233100: FMT.

What condition does NCT03233100 study?

NCT03233100 studies Constipation - Functional, Depressive Symptoms, Anxiety Symptoms, Gut-Brain Disorders.

Is NCT03233100 still recruiting?

NCT03233100 is currently status unknown. Last updated 28 July 2017.

Last reviewed 2017-07-28 · How we verify

NCT03233100

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms

Status unknown NA Last updated 28 July 2017

What this trial tests

NA trial testing FMT in Constipation - Functional in 40 participants. Status unknown.

Timeline

30 July 2017

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Jianfeng Gong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	30 July 2017
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across China

Drugs / interventions tested

FMT — full drug profile →

Conditions studied

Constipation - Functional — all drugs for Constipation - Functional →
Depressive Symptoms — all drugs for Depressive Symptoms →
Anxiety Symptoms — all drugs for Anxiety Symptoms →
Gut-Brain Disorders — all drugs for Gut-Brain Disorders →

Sponsor

Jianfeng Gong

Who can join

18 and older, any sex, with Constipation - Functional or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Constipated patients often have mental problems such as depression and anxiety due to difficult defecation. Our previous studies have proved the efficacy of FMT treating constipation. Meanwhile it is believed that mental diseases are correlated to gut microbiota. This trial is based on the theory of the gut-brain-microbiota axis. Patients with constipation, depression and/or anxiety are performed FMT, laboratory, imaging and microbiota examinations, and clinical follow-up, to observe the clinical efficiency of FMT and the potential role of gut microbiome in these gut-brain disorders.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K, Nieuwdorp M, Herrema H. · · 2019 · cited 111× · PMID 31201141 · DOI 10.1016/j.ebiom.2019.05.066
Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.
Xu HM, Huang HL, Zhou YL, Zhao HL, et al · · 2021 · cited 59× · PMID 33510784 · DOI 10.1155/2021/6699268

Verify or expand the search:

Other trials of FMT

Trials testing the same drug.

NCT07386795 — The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation · NA · not yet recruiting
NCT07387952 — The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of F · NA · recruiting
NCT07153809 — Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis · NA · recruiting
NCT06496191 — FMT for Alcohol Use Disorder in Cirrhotics. · NA · recruiting
NCT05740319 — Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome · NA · recruiting

Other recruiting trials for Constipation - Functional

Currently open trials in the same condition.

NCT07300423 — Parents of Children With Constipation Will be Asked About Their Views on Their Children's Physical Activity. · recruiting
NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
NCT07387952 — The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of F · NA · recruiting
NCT07340203 — Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation · active not recruiting
NCT07077044 — The Effects of TTNS, TTNS Combined With PHUS, and Conventional Therapy With PHUS in the Treatment of PFC. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03233100 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jianfeng Gong
Last refreshed: 28 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03233100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing